These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8054253)

  • 41. [Anti-arrhythmic therapy with verapamil by intravenous infusion].
    Furlanello F; Piccolo E; Disertori M; Trevi GP; Lanzetta T; Miori
    Minerva Med; 1975 May; 66(39):1887-903. PubMed ID: 1128829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-blind crossover randomized trial of intravenously administered verapamil. Its use for atrial fibrillation and flutter following open heart surgery.
    Hwang MH; Danoviz J; Pacold I; Rad N; Loeb HS; Gunnar RM
    Arch Intern Med; 1984 Mar; 144(3):491-4. PubMed ID: 6703818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolongation of verapamil elimination kinetics during chronic oral administration.
    Schwartz JB; Keefe DL; Kirsten E; Kates RE; Harrison DC
    Am Heart J; 1982 Aug; 104(2 Pt 1):198-203. PubMed ID: 7102502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.
    Dias VC; Weir SJ; Ellenbogen KA
    Circulation; 1992 Nov; 86(5):1421-8. PubMed ID: 1423955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
    Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L
    Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Supraventricular tachyarrhythmias: atrial flutter and atrial fibrillation.
    Rae AP
    Geriatrics; 1985 Mar; 40(3):93-5, 98, 103-5 passim. PubMed ID: 3972251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Re-evaluation of the use of verapamil in supraventricular tachyarrhythmias].
    Carvalho MA; Osterne EC; Bezerra FA; Carvalho PR; Barros RB; Carneiro RD
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():83-6. PubMed ID: 678167
    [No Abstract]   [Full Text] [Related]  

  • 49. [Acute treatment with verapamil of paroxysmal supraventricular tachycardia and atrial flutter in paediatric age (author's transl)].
    Musto B; Greco R; Calabrò R; Marsico F
    G Ital Cardiol; 1979; 9(4):368-73. PubMed ID: 456797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Efficacy and Safety of Intravenous Verapamil and Diltiazem for Rate Control in Rapidly Conducted Atrial Fibrillation and Atrial Flutter.
    Rajput FA; Du L; Chappell RJ; Berei TJ; Goldberger ZD; Wright JM
    J Gen Intern Med; 2020 Dec; 35(12):3721-3723. PubMed ID: 32710208
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
    Joshi PP; Deshmukh PK; Salkar RG
    J Assoc Physicians India; 1995 Aug; 43(8):529-31. PubMed ID: 8772970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A; Malfatti S
    Minerva Med; 1975 May; 66(39):1923-31. PubMed ID: 48221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A paroxysm of atrial flutter-fibrillation simulating ventricular tachycardia].
    Lipnitskiĭ TN; Denisiuk VI; Kolesnik PF; Stoliarchuk VA; Sizova MP
    Lik Sprava; 1992 Sep; (9):101-3. PubMed ID: 1481483
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of intravenous verapamil in cardiac arrhythmias.
    Slome R
    S Afr Med J; 1973 Jun; 47(21):913-4. PubMed ID: 4711004
    [No Abstract]   [Full Text] [Related]  

  • 58. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
    Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
    J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atrial fibrillation and flutter in children].
    Battaglia T; Attanà A; Fumarulo A; Paparo F; Primerano M; Martini B
    Minerva Med; 1982 Apr; 73(14):855-8. PubMed ID: 7070698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.